Osteoporosis is a progressive skeletal disease characterized by decreased bone mass and
degraded bone microstructure, which leads to increased bone fragility and risks of bone …

Osteoporosis is a systemic metabolic bone disorder characterized by a decrease in bone
mass and degradation of the bone microstructure, leaving bones that are fragile and prone …

The formation, maintenance, and repair of bone tissue involve close interlinks between two
stem cell types housed in the bone marrow: the hematologic stem cell originating …

Osteoporosis, or bone loss, is a progressive, systemic skeletal disease that affects millions of
people worldwide. Osteoporosis is generally age related, and it is underdiagnosed because …

Bone marrow-derived mesenchymal stem cells (MSCs) are adherent cells that differentiate
into chondroblasts, osteoblasts and adipocytes. In this short review, we summarize the …

Mesenchymal Stem Cells (MSCs) from bone marrow stroma are capable of differentiating
into osteoblasts and adipocytes, among other cell phenotypes. In normal bone marrow …

Mesenchymal stem cells (MSCs) are a major component of various forms of tissue
engineering. MSCs have self‐renewal and multidifferential potential. Osteogenic …

Senile osteoporosis has become a worldwide bone disease with the aging of the world
population. It increases the risk of bone fracture and seriously affects human health. Unlike …

Human mesenchymal stem cells (hMSCs) are considered a promising cell source for
regenerative medicine, because they have the potential to differentiate into a variety of …

Bone tissue engineering (BTE) is now a promising research issue to improve the drawbacks
from traditional bone grafting procedure such as limited donor sources and possible …